|
Jeffrey Martin is a seasoned business executive from the medical device industry. In 2005, under Martin s leadership, Yulex Corporation became the first commercial enterprise to produce nonallergenic natural rubber latex in the U.S. Prior to co-founding Yulex, Martin was corporate officer and Vice President of Sales for Safeskin Corporation, a leading manufacturer and marketer of latex medical devices throughout the U.S. and Europe. Martin joined Safeskin prior to its successful IPO and was instrumental in positioning the company as "The Best Small Company in America" (Forbes Magazine,1996). During his tenure, Martin also held the position of Vice President of Marketing/Business Development for North American and European operations, where sales grew from $55 million to $235 million in six years. Martin was responsible for the acquisition of Tactyl Technologies where he was elected a director in 1996. Martin was the first sales executive hired for London Rubber Company s (Regent Medical) U.S. startup operations in 1986, where he established sales and distribution functions for the new enterprise which subsequently became a global leader in the surgical glove market. Prior to Regent, Martin held positions as both a scientist in R&D and a sales executive with the Professional Healthcare Group of the Kimberly-Clark Corporation. He began his career in medical products in 1975 with the Ethicon division of Johnson & Johnson, Inc., in the Polymer Development Department, conducting research on surgical adhesives and sutures. Martin has a formal education in engineering from the Georgia Institute of Technology where he was recently inducted into the Academy of Distinguished Engineering Alumni. Martin is an active member of BIOCOM in San Diego and a member of PAPSAC which is an agricultural industry oversight panel of academic, government and industry leaders at the John F. Kennedy School of Government, Harvard University. | 